UK customs regulators have been put under scrutiny after the cure for Ebola was impounded after a fatal crash of its transport vehicle.
The agency that dealt with the incident took the samples, manifests and other secure data that was being sent to the WHO London laboratory for trails. It is believed that the formula for the cure was copied and given to an unknown third party. It is believed that this third party had pressured senior staff to seize the cure and pass on the information included with it.
Investigators believe that it is linked to possible insider trading, as owning the cure could significantly increase share prices of a company.